Varta
← Back to stories

From NDTV

Center-Right Owned by Adani Group (AMG Media)

Biocon Q2 Results: Net Profit Falls 51% To Rs 41 Crore, Revenue Rises 2% YoY; Misses Estimates

Biocon Q2 Results: Net Profit Falls 51% To Rs 41 Crore, Revenue Rises 2% YoY; Misses Estimates

What's behind this

Sundaram Finance, a Chennai‑based non‑bank financial company, reported a 21% rise in its Q2 profit after tax to ₹475 crore, while its loan disbursements increased by 28% over the same period. The firm also saw assets under management grow 19% to ₹65,992 crore, and its net Stage 3 asset proportion improved to 0.91% as of the end of September.

AI-generated overview from 3 outlets. It summarises their reporting and adds no reporting of its own.

What each side is saying

One outlet's own words from each side of the spectrum. Quoted, not summarised.

  • center · 3 outlets

    Listed eyewear company Lenskart reported a 124.7% jump in its consolidated net profit to ₹232.5 Cr in the September quarter…

    — Inc42

  • right · 2 outlets

    Q2 Results Today, 04th November 2026 Live Updates: businessline brings you the latest quarterly earnings, outlook and more.

    — The Hindu BusinessLine

RSS excerpt

Biocon's consolidated revenue from operations in Q2FY27 grew 2.2% to Rs 4,389 crore from Rs 4,296 crore, year-on-year (YoY).Biosimilars revenue increased 3% YoY to Rs 2,809 crore and Generics revenue grew 10% YoY Rs 774 crore.

Coverage arrived over 8 hours — first from NDTV, latest from The Hindu BusinessLine.

✓ High Corroboration ⚡ Cross-Spectrum Consensus 5 news outlets reporting

Fact-Check & Bias Analysis

Confirmed by multiple independent newsrooms across the political spectrum.

Coverage Bias Distribution

Based on 5 reporting publishers
Left / Center-Left 0 (0%)
Center 3 (60%)
Center-Right / Right 2 (40%)
Left Blindspot: Little to no coverage from left-leaning outlets.

Compare all reporting outlets (5)

NDTV Center-Right Adani Group (AMG Media) Current article

Biocon Q2 Results: Net Profit Falls 51% To Rs 41 Crore, Revenue Rises 2% YoY; Misses Estimates

Biocon's consolidated revenue from operations in Q2FY27 grew 2.2% to Rs 4,389 crore from Rs 4,296 crore, year-on-year (YoY).Biosimilars revenue increased 3% YoY to Rs 2,809 crore and Generics revenue grew 10% YoY Rs 774 crore.

Read more news

See all latest stories →